subject area of
- A phase i clinical trial of the hu14.18-il2 (emd 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the children's oncology group Academic Article
- Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice Academic Article
- Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry Academic Article
- Extended follow-up of patients with hairy cell leukemia after treatment with cladribine Academic Article
- Extensive disease small cell-carcinoma of the lung - trial of non-cross resistant chemotherapy and consolidation radiotherapy Academic Article
- Genetic variation in pro-inflammatory cytokines (interleukin-1 beta, interleukin-1 alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma Academic Article
- Interleukin-2 gene-therapy in a patient with glioblastoma Academic Article
- Long-term follow-up of patients with hairy cell leukemia after cladribine treatment Academic Article
- Memento Mori Academic Article
- Metabolomic signatures of aggressive prostate cancer Academic Article
- NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells Academic Article
- Nxs2 murine neuroblastomas express increased levels of mhc class i antigens upon recurrence following nk-dependent immunotherapy Academic Article
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function Academic Article
- Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers Academic Article
- Targeted therapeutic remodeling of the tumor microenvironment improves an her-2 DNA vaccine and prevents recurrence in a murine breast cancer model Academic Article
- The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model Academic Article